RxDoctor Payments Data

Monica Watts, MD

Family Medicine · Senoia, GANPI 1043356355

Payments from drug & device makers

$6,010in general payments, 2019–2025

Across 359 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$917
  • Amgen$785
  • Astellas Pharma US Inc$528
  • Lilly USA, LLC$508
  • AstraZeneca$493
  • Pfizer$435
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,79196%
  • Education$2184%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,010 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$55,371
Medicare patients
168
Services billed
1,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide71$106,055
MounjaroTirzepatide69$100,524
JardianceEmpagliflozin54$66,048
FarxigaDapagliflozin Propanediol54$60,772
EliquisApixaban42$44,476
TrulicityDulaglutide24$41,502
JanuviaSitagliptin Phosphate25$27,991
MyrbetriqMirabegron25$23,508
XareltoRivaroxaban20$18,091
Soliqua 100-33Insulin Glargine/Lixisenatide11$14,383
LinzessLinaclotide16$14,025
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$6,462
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen150$5,136
Sumatriptan Succinate17$4,603
Albuterol Sulfate HfaAlbuterol Sulfate125$4,417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$508$142,02693 claims
Novo NordiskOzempic$917$106,05571 claims
Boehringer IngelheimJardiance$134$66,04854 claims
AstraZenecaFarxiga$493$60,77254 claims
PfizerEliquis$435$44,47642 claims
MerckJanuvia$52$27,99125 claims
Astellas Pharma US IncMyrbetriq$528$23,50825 claims
Johnson & JohnsonXarelto$40$18,09120 claims
AbbVieLinzess, Synthroid$297$15,37329 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$143$14,38311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Senoia

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →